NCT07104292

Brief Summary

The project seeks to investigate effectiveness of PFMT during pregnancy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
734

participants targeted

Target at P75+ for not_applicable

Timeline
28mo left

Started Oct 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
Oct 2025Aug 2028

First Submitted

Initial submission to the registry

July 10, 2025

Completed
26 days until next milestone

First Posted

Study publicly available on registry

August 5, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

October 27, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2028

Last Updated

November 28, 2025

Status Verified

November 1, 2025

Enrollment Period

1.8 years

First QC Date

July 10, 2025

Last Update Submit

November 21, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Urinary incontinence (UI) incidence at 3 months postpartum

    International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) score between 0 (perfect continence) and 21 (total incontinence).

    At 3 months follow-up after giving birth

Secondary Outcomes (31)

  • Urinary incontinence at the 1st trimester of pregnancy

    At baseline, during the 1st trimester of pregnancy (gestational age (GA) up to 12 weeks +6 days)

  • Urinary incontinence at the 2nd trimester of pregnancy

    At the follow-up at Gestational age 26 weeks and 0 days

  • Urinary incontinence incidence at the 3rd trimester of pregnancy

    At the follow-up at Gestational Age 36 weeks and 0 days

  • Urinary incontinence incidence at 6 weeks postpartum

    At the follow-up at 6 weeks postpartum

  • Anal incontinence (AI) incidence at inclusion, during the 1st trimester of pregnancy

    At baseline, during the 1st trimester of pregnancy (gestational age (GA) up to 12 weeks +6 days)

  • +26 more secondary outcomes

Study Arms (2)

Pelvic Floor Muscle Training (PFMT)

EXPERIMENTAL

A Danish professional pelvic floor physiotherapist together with a midwife and an urogynecologist have created a free of charge training program, which is easily accessible via a danish website "www.kvindekrop.dk" or via the app "Pelvic FloorTrainer". The women will receive an easily accessible, home-based PFMT program electronically in which they will be motivated to start and engage during pregnancy with continuity after birth.

Behavioral: PFMT

Standard care

PLACEBO COMPARATOR

The control group will receive routine care - recommendation to do the training without any further instructions.

Behavioral: Standard care

Interventions

PFMTBEHAVIORAL

The motivation-informed intervention will tackle both exercise engagement and exercise adherence. Participating women will be introduced to the app and its videos following training. The participants will be introduced not only to muscle training, but also to muscle relaxation. The training will be recommended three to four times a week during pregnancy with further continuity after giving birth.

Pelvic Floor Muscle Training (PFMT)
Standard careBEHAVIORAL

Standard care

Standard care

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Woman in the 1st trimester of pregnancy (up to 12+6 weeks of gestation)
  • Para 0 (no previous birth or pregnancy \> 16 weeks of gestation)
  • Understands, writes, and reads fluently in Danish or English
  • Has a smart phone or computer/tablet to reach the training program

You may not qualify if:

  • Severe psychiatric illness (e.g. schizophrenia, bipolar disorder, severe depression or anxiety)
  • Active substance abuse
  • Acute social crises (e.g. homelessness, ongoing domestic violence, severe financial instability, lack of social support)
  • Women with limited capacity to provide informed consent (due to cognitive impairment or language barriers)
  • Previous pregnancy of \> 16 weeks of gestation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sygehus Sønderjylland

Aabenraa, Southern Denmark, 6200, Denmark

RECRUITING

MeSH Terms

Conditions

Urinary IncontinenceEncopresisPelvic Organ ProlapseSexual Dysfunction, Physiological

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, DigestiveBehavioral SymptomsBehaviorElimination DisordersMental DisordersProlapsePathological Conditions, AnatomicalGenital Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Jan Stener Jørgensen

    University Hospital of Southern Denmark

    STUDY CHAIR

Central Study Contacts

Christina Prinds

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2025

First Posted

August 5, 2025

Study Start

October 27, 2025

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

August 1, 2028

Last Updated

November 28, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations